Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Butterfly Network, Inc.BFLY · Entity 4467 | EVP, CFO & COO | May 05, 2025 | May 07, 2025 |
| MYOMO, INC.MYO · Entity 7135 | Director | June 25, 2026 | June 26, 2026 |
| TELA Bio, Inc.TELA · Entity 7381 | Director · Chief Executive Officer | August 17, 2026 | August 19, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Butterfly Network, Inc.
Report date May 05, 2025 · Filed May 07, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 2,919,274 |
Reported balance
After 2025-05-05 transaction · row 1
1 source rowRow 1 · 2025-05-05 · Sale · Disposed 65,456 · Balance 2,919,274 F1: The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2: Represents the weighted average sales price per share. The shares sold at prices ranging from $2.175 to $2.28 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
F2: Represents the weighted average sales price per share. The shares sold at prices ranging from $2.175 to $2.28 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
MYOMO, INC.
Report date June 25, 2026 · Filed June 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 210,458 |
Reported balance
After 2026-06-25 transaction · row 1
1 source rowRow 1 · 2026-06-25 · Grant · Acquired 78,704 · Balance 210,458 F1: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vest in four quarterly installments beginning on September 9, 2026. The Reporting Person has elected to defer the receipt of common stock upon the vesting of the RSUs until the earlier of (i) the date that is thirty (30) days following the date of termination of service and (ii) the date of a change in control. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vest in four quarterly installments beginning on September 9, 2026. The Reporting Person has elected to defer the receipt of common stock upon the vesting of the RSUs until the earlier of (i) the date that is thirty (30) days following the date of termination of service and (ii) the date of a change in control.
TELA Bio, Inc.
Report date August 17, 2026 · Filed August 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 532,500 |
Reported balance
After 2026-08-17 transaction · row 1
1 source rowRow 1 · 2026-08-17 · Purchase · Acquired 12,500 · Balance 532,500 F1: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.6504 to $0.6749. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.6504 to $0.6749. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
BIOTELEMETRY, INC.
Report date February 09, 2021 · Filed February 12, 2021
Section 16 reporting ended · disclosed 2021-02-12. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-02-09 transaction · row 1
1 source rowRow 1 · 2021-02-09 · Disposition to issuer · Disposed 49,947 · Balance 0 F1: Per the terms of the Agreement and Plan of Merger, dated as of December 18, 2020, among the Company, Philips Holding USA Inc., a Delaware corporation, and Davies Merger Sub, Inc., a Delaware corporation (the "Merger Agreement") and the Offer (as defined in the Merger Agreement), each share of Company common stock was validly tendered for $72.00 per share in cash (the "Offer Price"), less any applicable withholding taxes. F2: Includes 21,390 restricted stock units that, pursuant to the Merger Agreement, were cancelled at the Effective Time of the Merger (both as defined in the Merger Agreement) and converted into the right to receive the Offer Price, less any applicable withholding taxes. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.68 · Expires 2024-02-14 | Direct | 0 |
Reported balance
After 2021-02-09 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-02-09 · Disposition to issuer · Disposed 23,578 · Balance 0 F3: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the total number of shares of Company common stock subject to such stock option immediately prior to the Effective Time, and (ii) the excess, if any, of the Offer Price over the exercise price per share of such stock option, less applicable withholding taxes. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.36 · Expires 2025-02-16 | Direct | 0 |
Reported balance
After 2021-02-09 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-02-09 · Disposition to issuer · Disposed 29,040 · Balance 0 F3: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the total number of shares of Company common stock subject to such stock option immediately prior to the Effective Time, and (ii) the excess, if any, of the Offer Price over the exercise price per share of such stock option, less applicable withholding taxes. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.57 · Expires 2026-02-15 | Direct | 0 |
Reported balance
After 2021-02-09 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-02-09 · Disposition to issuer · Disposed 22,455 · Balance 0 F3: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the total number of shares of Company common stock subject to such stock option immediately prior to the Effective Time, and (ii) the excess, if any, of the Offer Price over the exercise price per share of such stock option, less applicable withholding taxes. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $24.65 · Expires 2027-02-14 | Direct | 0 |
Reported balance
After 2021-02-09 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-02-09 · Disposition to issuer · Disposed 10,675 · Balance 0 F3: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the total number of shares of Company common stock subject to such stock option immediately prior to the Effective Time, and (ii) the excess, if any, of the Offer Price over the exercise price per share of such stock option, less applicable withholding taxes. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $33.35 · Expires 2028-02-14 | Direct | 0 |
Reported balance
After 2021-02-09 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-02-09 · Disposition to issuer · Disposed 18,991 · Balance 0 F3: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the total number of shares of Company common stock subject to such stock option immediately prior to the Effective Time, and (ii) the excess, if any, of the Offer Price over the exercise price per share of such stock option, less applicable withholding taxes. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $53.22 · Expires 2030-02-17 | Direct | 0 |
Reported balance
After 2021-02-09 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2021-02-09 · Disposition to issuer · Disposed 10,634 · Balance 0 F3: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the total number of shares of Company common stock subject to such stock option immediately prior to the Effective Time, and (ii) the excess, if any, of the Offer Price over the exercise price per share of such stock option, less applicable withholding taxes. |
| Performance Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2021-02-14 | Direct | 0 |
Reported balance
After 2021-02-09 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2021-02-09 · Disposition to issuer · Disposed 7,977 · Balance 0 F4: Per the terms of the Merger Agreement, each performance stock unit ("PSU") that was outstanding as of the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash equal to the product of (i) the total number of shares of Company common stock subject to such PSU that would have vested if the applicable performance period ended immediately prior to the Effective Time (assuming that any applicable performance conditions were deemed to be achieved at the target performance level), multiplied by (ii) the Offer Price, less applicable withholding taxes. |
| Performance Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2022-02-14 | Direct | 0 |
Reported balance
After 2021-02-09 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2021-02-09 · Disposition to issuer · Disposed 1,987 · Balance 0 F4: Per the terms of the Merger Agreement, each performance stock unit ("PSU") that was outstanding as of the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash equal to the product of (i) the total number of shares of Company common stock subject to such PSU that would have vested if the applicable performance period ended immediately prior to the Effective Time (assuming that any applicable performance conditions were deemed to be achieved at the target performance level), multiplied by (ii) the Offer Price, less applicable withholding taxes. |
| Performance Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-02-09 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2021-02-09 · Disposition to issuer · Disposed 6,426 · Balance 0 F4: Per the terms of the Merger Agreement, each performance stock unit ("PSU") that was outstanding as of the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash equal to the product of (i) the total number of shares of Company common stock subject to such PSU that would have vested if the applicable performance period ended immediately prior to the Effective Time (assuming that any applicable performance conditions were deemed to be achieved at the target performance level), multiplied by (ii) the Offer Price, less applicable withholding taxes. |
Filing footnotes · ownership attribution and instrument terms
F1: Per the terms of the Agreement and Plan of Merger, dated as of December 18, 2020, among the Company, Philips Holding USA Inc., a Delaware corporation, and Davies Merger Sub, Inc., a Delaware corporation (the "Merger Agreement") and the Offer (as defined in the Merger Agreement), each share of Company common stock was validly tendered for $72.00 per share in cash (the "Offer Price"), less any applicable withholding taxes.
F2: Includes 21,390 restricted stock units that, pursuant to the Merger Agreement, were cancelled at the Effective Time of the Merger (both as defined in the Merger Agreement) and converted into the right to receive the Offer Price, less any applicable withholding taxes.
F3: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the total number of shares of Company common stock subject to such stock option immediately prior to the Effective Time, and (ii) the excess, if any, of the Offer Price over the exercise price per share of such stock option, less applicable withholding taxes.
F4: Per the terms of the Merger Agreement, each performance stock unit ("PSU") that was outstanding as of the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash equal to the product of (i) the total number of shares of Company common stock subject to such PSU that would have vested if the applicable performance period ended immediately prior to the Effective Time (assuming that any applicable performance conditions were deemed to be achieved at the target performance level), multiplied by (ii) the Offer Price, less applicable withholding taxes.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 17, 2026 Filed Aug 19, 2026 20:10 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock | 12,500 | $0.66 | $8,311.25 |
DisclosureSEC source: 0001481485-26-000008 · form4-08192026_040807.xml · nonDerivative · entry 1 Getz Heather C · CIK 0001481485 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 532,500 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.6504 to $0.6749. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| August 14, 2026 Filed Aug 17, 2026 20:32 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock | 15,000 | $0.70 | $10,467.00 |
DisclosureSEC source: 0001481485-26-000006 · form4-08172026_080836.xml · nonDerivative · entry 1 Getz Heather C · CIK 0001481485 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 520,000 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.697 to $0.6994. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:09 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantStock Option (Right to Buy) · Derivative | 1,005,000 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001481485-26-000004 · form4-08052026_080838.xml · derivative · entry 3 Getz Heather C · CIK 0001481485 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,005,000 Underlying: Common Stock · 1,005,000 shares Expires 2036-08-03 F2 · derivative.exercise_date: The option vests 25% on August 3, 2027, with the remaining 75% vesting in equal monthly installments over 36 months thereafter, subject to the Reporting Person's continued service through the applicable vesting dates. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:09 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantStock Option (Right to Buy) · Derivative | 1,365,000 | $0.00 Strike: $0.74 | $0.00 |
DisclosureSEC source: 0001481485-26-000004 · form4-08052026_080838.xml · derivative · entry 2 Getz Heather C · CIK 0001481485 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,365,000 Underlying: Common Stock · 1,365,000 shares Expires 2036-08-03 F2 · derivative.exercise_date: The option vests 25% on August 3, 2027, with the remaining 75% vesting in equal monthly installments over 36 months thereafter, subject to the Reporting Person's continued service through the applicable vesting dates. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:09 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantCommon Stock | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001481485-26-000004 · form4-08052026_080838.xml · nonDerivative · entry 1 Getz Heather C · CIK 0001481485 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 505,000 F1 · shares: These restricted stock units will vest in four equal annual installments beginning on August 3, 2027, in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 25, 2026 Filed Jun 26, 2026 21:11 UTC | MYOMO, INC. MYO · Entity 7135 | GrantCommon Stock | 78,704 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-285696 · ownership.xml · nonDerivative · entry 1 Getz Heather C · CIK 0001481485 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 210,458 F1 · shares: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vest in four quarterly installments beginning on September 9, 2026. The Reporting Person has elected to defer the receipt of common stock upon the vesting of the RSUs until the earlier of (i) the date that is thirty (30) days following the date of termination of service and (ii) the date of a change in control. Read SEC document |
| March 16, 2026 Filed Mar 17, 2026 21:39 UTC | MYOMO, INC. MYO · Entity 7135 | PurchaseCommon Stock | 20,000 | $0.70 | $13,972.00 |
DisclosureSEC source: 0001193125-26-111290 · ownership.xml · nonDerivative · entry 1 Getz Heather C · CIK 0001481485 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,754 F1 · shares: Represents open market purchase in a single transaction. Read SEC document |
| March 12, 2026 Filed Mar 12, 2026 21:18 UTC | MYOMO, INC. MYO · Entity 7135 | PurchaseCommon Stock | 70,000 | $0.73 | $50,960.00 |
DisclosureSEC source: 0001193125-26-104456 · ownership.xml · nonDerivative · entry 1 Getz Heather C · CIK 0001481485 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,754 F1 · shares: Represents open market purchases. Shares were purchased in multiple lots at prices ranging from $0.72 to $0.73 per share. Reporting Party agrees to provide details of the transactions to the SEC upon request. F2 · price: Represents weighted average purchase price Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 23:34 UTC | MYOMO, INC. MYO · Entity 7135 | GrantCommon Stock | 29,720 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-085722 · ownership.xml · nonDerivative · entry 1 Getz Heather C · CIK 0001481485 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,754 F1 · shares: Represents grant of Restricted Stock Units ("RSU's") under the Issuer's 2018 Stock Option and Incentive Plan. These RSU's shall vest in four equal quarterly installments beginning on September 11, 2025. Read SEC document |
| May 05, 2025 Filed May 7, 2025 20:18 UTC | Butterfly Network, Inc. BFLY · Entity 4467 | SaleClass A Common Stock | 65,456 | $2.20 | $144,068.66 |
DisclosureSEC source: 0001062993-25-008764 · form4.xml · nonDerivative · entry 1 Getz Heather C · CIK 0001481485 · EVP, CFO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,919,274 F1 · kind: The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $2.175 to $2.28 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 02:06 UTC | Butterfly Network, Inc. BFLY · Entity 4467 | Tax withholdingClass A Common Stock | 282,649 | $3.03 | $856,426.47 |
DisclosureSEC source: 0001062993-25-004454 · form4.xml · nonDerivative · entry 2 Getz Heather C · CIK 0001481485 · EVP, CFO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,984,730 F3 · kind: Shares withheld by the Registrant to cover tax withholding obligations in connection with the vesting of RSUs that were granted on March 1, 2023 and March 6, 2024. Read SEC document |
| March 01, 2025 Filed Mar 5, 2025 02:06 UTC | Butterfly Network, Inc. BFLY · Entity 4467 | GrantClass A Common Stock | 569,211 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-004454 · form4.xml · nonDerivative · entry 1 Getz Heather C · CIK 0001481485 · EVP, CFO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,267,379 F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A Common Stock upon vesting. The RSUs vest in three equal annual installments following March 1, 2025, subject to the Reporting Person's continued service on each such vesting date. F2 · balance_after: Includes 28,835 shares acquired under the Issuer's employee stock purchase plan on December 31, 2024. Read SEC document |
| December 20, 2024 Filed Dec 26, 2024 21:15 UTC | Butterfly Network, Inc. BFLY · Entity 4467 | SaleClass A Common Stock | 30,136 | $3.06 | $92,336.70 |
DisclosureSEC source: 0001104659-24-131720 · tm2432065-2_4seq1.xml · nonDerivative · entry 1 Getz Heather C · CIK 0001481485 · EVP, CFO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,669,333 F1 · kind: The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $2.845 to $3.23 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:27 UTC | MYOMO, INC. MYO · Entity 7135 | GrantCommon Stock | 12,034 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-070689 · ownership.xml · nonDerivative · entry 1 Getz Heather C · CIK 0001481485 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,034 F1 · shares: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vest in quarterly installments over one year beginning on September 7, 2024. Read SEC document |
| May 03, 2024 Filed May 7, 2024 20:15 UTC | Butterfly Network, Inc. BFLY · Entity 4467 | SaleClass A Common Stock | 59,848 | $0.95 | $57,035.14 |
DisclosureSEC source: 0001104659-24-058011 · tm2413768-1_4seq1.xml · nonDerivative · entry 1 Getz Heather C · CIK 0001481485 · EVP, CFO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,699,469 F1 · kind: The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $0.9101 to $0.9937 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:30 UTC | Butterfly Network, Inc. BFLY · Entity 4467 | SaleClass A Common Stock | 81,448 | $1.14 | $92,850.72 |
DisclosureSEC source: 0001104659-24-033950 · tm248687-1_4seq1.xml · nonDerivative · entry 1 Getz Heather C · CIK 0001481485 · EVP, CFO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,435,788 F1 · kind: The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $1.10 to $1.21 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| March 06, 2024 Filed Mar 25, 2024 22:06 UTC | Butterfly Network, Inc. BFLY · Entity 4467 | GrantClass A Common Stock | 1,323,529 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-038526 · tm249494-2_4seq1.xml · nonDerivative · entry 1 Getz Heather C · CIK 0001481485 · EVP, CFO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,840,765 F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A Common Stock upon vesting. The RSUs vest as follows: (i) 882,353 RSUs vest in three equal annual installments following March 1, 2024 and (ii) 441,176 RSUs vest in two equal annual installments following March 1, 2024, in each case subject to the Reporting Person's continued service on each such vesting date. F2 · balance_after: Represents the number of shares owned by the Reporting Person following the reported transaction. As of the date of this filing, the Reporting Person owns 2,759,317 shares of Class A Common Stock. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 21:13 UTC | Butterfly Network, Inc. BFLY · Entity 4467 | SaleClass A Common Stock | 66,142 | $1.02 | $67,464.84 |
DisclosureSEC source: 0001062993-24-000701 · form4.xml · nonDerivative · entry 1 Getz Heather C · CIK 0001481485 · EVP, CFO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,517,236 F1 · kind: The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $1.00 to $1.05 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| July 13, 2023 Filed Jul 14, 2023 21:06 UTC | Butterfly Network, Inc. BFLY · Entity 4467 | GrantClass A Common Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-081287 · tm2321396d1_4.xml · nonDerivative · entry 1 Getz Heather C · CIK 0001481485 · EVP, CFO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,583,378 F1 · shares: Consists of performance-based RSUs. The RSUs underlying this grant shall vest as follows: (i) one-third shall vest upon the achievement of a price for the Common Stock equal to or exceeding $3.00 per share, (ii) one-third shall vest upon the achievement of a price for the Common Stock equal to or exceeding $4.50 per share and (iii) one-third shall vest upon the achievement of a price for the Common Stock equal to or exceeding $6.00 per share. In each case, the closing stock price for 20 consecutive trading days must equal or exceed the share price targets, provided such share price is achieved prior to July 13, 2028, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| July 05, 2023 Filed Jul 6, 2023 21:43 UTC | Butterfly Network, Inc. BFLY · Entity 4467 | SaleClass A Common Stock | 65,577 | $2.19 | $143,482.48 |
DisclosureSEC source: 0001104659-23-078834 · tm2320777-2_4seq1.xml · nonDerivative · entry 1 Getz Heather C · CIK 0001481485 · EVP & Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,383,378 F1 · kind: The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and intended to qualify under Rule 10b5-1. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $2.15 to $2.315 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:15 UTC | Butterfly Network, Inc. BFLY · Entity 4467 | SaleClass A Common Stock | 64,536 | $1.98 | $127,523.14 |
DisclosureSEC source: 0001140361-23-023212 · form4.xml · nonDerivative · entry 1 Getz Heather C · CIK 0001481485 · EVP & Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,448,955 F1 · kind: The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and intended to qualify under Rule 10b5-1. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $1.91 to $2.025 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:04 UTC | Butterfly Network, Inc. BFLY · Entity 4467 | GrantClass A Common Stock | 600,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-002440 · primarydocument.xml · nonDerivative · entry 2 Getz Heather C · CIK 0001481485 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,513,491 F2 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 33.33% on each anniversary of the grant date, subject to Ms. Getz's continued service through the applicable vesting date. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:04 UTC | Butterfly Network, Inc. BFLY · Entity 4467 | GrantClass A Common Stock | 285,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-002440 · primarydocument.xml · nonDerivative · entry 1 Getz Heather C · CIK 0001481485 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 913,491 F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 50% on July 1, 2023 with the remainder vesting on January 1, 2024, subject to Ms. Getz's continued service through the applicable vesting date. Read SEC document |
| May 02, 2022 Filed May 4, 2022 20:17 UTC | Butterfly Network, Inc. BFLY · Entity 4467 | GrantStock Option (right to buy) · Derivative | 314,915 | $0.00 Strike: $3.58 | $0.00 |
DisclosureSEC source: 0001104659-22-055840 · tm2214349-2_4seq1.xml · derivative · entry 2 Getz Heather C · CIK 0001481485 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,915 Underlying: Class A Common Stock · 314,915 shares Expires 2032-05-02 F2 · derivative.exercise_date: The shares underlying this option vest as to 25% on May 2, 2023, with the remainder vesting in 36 equal monthly installments thereafter, subject to Ms. Getz's continued service through the applicable vesting date. Read SEC document |
| May 02, 2022 Filed May 4, 2022 20:17 UTC | Butterfly Network, Inc. BFLY · Entity 4467 | GrantClass A Common Stock | 628,491 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-055840 · tm2214349-2_4seq1.xml · nonDerivative · entry 1 Getz Heather C · CIK 0001481485 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 628,491 F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 25% on May 2, 2023, with the remainder vesting in three equal annual installments thereafter, subject to Ms. Getz's continued service through the applicable vesting date. Read SEC document |
| February 09, 2021 Filed Feb 12, 2021 02:49 UTC | BIOTELEMETRY, INC. BEAT · Entity 142764 | Disposition to issuerPerformance Stock Units · Derivative | 6,426 | $72.00 Strike: $0.00 | $462,672.00 |
DisclosureSEC source: 0000899243-21-006176 · doc4.xml · derivative · entry 10 Getz Heather C · CIK 0001481485 · EVP, CFO & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,426 shares Expires not disclosed F4 · derivative.exercise_date: Per the terms of the Merger Agreement, each performance stock unit ("PSU") that was outstanding as of the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash equal to the product of (i) the total number of shares of Company common stock subject to such PSU that would have vested if the applicable performance period ended immediately prior to the Effective Time (assuming that any applicable performance conditions were deemed to be achieved at the target performance level), multiplied by (ii) the Offer Price, less applicable withholding taxes. F4 · derivative.expiration_date: Per the terms of the Merger Agreement, each performance stock unit ("PSU") that was outstanding as of the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash equal to the product of (i) the total number of shares of Company common stock subject to such PSU that would have vested if the applicable performance period ended immediately prior to the Effective Time (assuming that any applicable performance conditions were deemed to be achieved at the target performance level), multiplied by (ii) the Offer Price, less applicable withholding taxes. Read SEC document |
| February 09, 2021 Filed Feb 12, 2021 02:49 UTC | BIOTELEMETRY, INC. BEAT · Entity 142764 | Disposition to issuerPerformance Stock Units · Derivative | 1,987 | $72.00 Strike: $0.00 | $143,064.00 |
DisclosureSEC source: 0000899243-21-006176 · doc4.xml · derivative · entry 9 Getz Heather C · CIK 0001481485 · EVP, CFO & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,987 shares Expires 2022-02-14 F4 · derivative.exercise_date: Per the terms of the Merger Agreement, each performance stock unit ("PSU") that was outstanding as of the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash equal to the product of (i) the total number of shares of Company common stock subject to such PSU that would have vested if the applicable performance period ended immediately prior to the Effective Time (assuming that any applicable performance conditions were deemed to be achieved at the target performance level), multiplied by (ii) the Offer Price, less applicable withholding taxes. Read SEC document |
| February 09, 2021 Filed Feb 12, 2021 02:49 UTC | BIOTELEMETRY, INC. BEAT · Entity 142764 | Disposition to issuerPerformance Stock Units · Derivative | 7,977 | $72.00 Strike: $0.00 | $574,344.00 |
DisclosureSEC source: 0000899243-21-006176 · doc4.xml · derivative · entry 8 Getz Heather C · CIK 0001481485 · EVP, CFO & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,977 shares Expires 2021-02-14 F4 · derivative.exercise_date: Per the terms of the Merger Agreement, each performance stock unit ("PSU") that was outstanding as of the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash equal to the product of (i) the total number of shares of Company common stock subject to such PSU that would have vested if the applicable performance period ended immediately prior to the Effective Time (assuming that any applicable performance conditions were deemed to be achieved at the target performance level), multiplied by (ii) the Offer Price, less applicable withholding taxes. Read SEC document |
| February 09, 2021 Filed Feb 12, 2021 02:49 UTC | BIOTELEMETRY, INC. BEAT · Entity 142764 | Disposition to issuerStock Options (Right to Buy) · Derivative | 10,634 | $18.78 Strike: $53.22 | $199,706.52 |
DisclosureSEC source: 0000899243-21-006176 · doc4.xml · derivative · entry 7 Getz Heather C · CIK 0001481485 · EVP, CFO & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,634 shares Expires 2030-02-17 F3 · derivative.exercise_date: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the total number of shares of Company common stock subject to such stock option immediately prior to the Effective Time, and (ii) the excess, if any, of the Offer Price over the exercise price per share of such stock option, less applicable withholding taxes. Read SEC document |
| February 09, 2021 Filed Feb 12, 2021 02:49 UTC | BIOTELEMETRY, INC. BEAT · Entity 142764 | Disposition to issuerStock Options (Right to Buy) · Derivative | 18,991 | $38.65 Strike: $33.35 | $734,002.15 |
DisclosureSEC source: 0000899243-21-006176 · doc4.xml · derivative · entry 6 Getz Heather C · CIK 0001481485 · EVP, CFO & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,991 shares Expires 2028-02-14 F3 · derivative.exercise_date: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the total number of shares of Company common stock subject to such stock option immediately prior to the Effective Time, and (ii) the excess, if any, of the Offer Price over the exercise price per share of such stock option, less applicable withholding taxes. Read SEC document |
| February 09, 2021 Filed Feb 12, 2021 02:49 UTC | BIOTELEMETRY, INC. BEAT · Entity 142764 | Disposition to issuerStock Options (Right to Buy) · Derivative | 10,675 | $47.35 Strike: $24.65 | $505,461.25 |
DisclosureSEC source: 0000899243-21-006176 · doc4.xml · derivative · entry 5 Getz Heather C · CIK 0001481485 · EVP, CFO & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,675 shares Expires 2027-02-14 F3 · derivative.exercise_date: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the total number of shares of Company common stock subject to such stock option immediately prior to the Effective Time, and (ii) the excess, if any, of the Offer Price over the exercise price per share of such stock option, less applicable withholding taxes. Read SEC document |
| February 09, 2021 Filed Feb 12, 2021 02:49 UTC | BIOTELEMETRY, INC. BEAT · Entity 142764 | Disposition to issuerStock Options (Right to Buy) · Derivative | 22,455 | $62.43 Strike: $9.57 | $1,401,865.65 |
DisclosureSEC source: 0000899243-21-006176 · doc4.xml · derivative · entry 4 Getz Heather C · CIK 0001481485 · EVP, CFO & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,455 shares Expires 2026-02-15 F3 · derivative.exercise_date: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the total number of shares of Company common stock subject to such stock option immediately prior to the Effective Time, and (ii) the excess, if any, of the Offer Price over the exercise price per share of such stock option, less applicable withholding taxes. Read SEC document |
| February 09, 2021 Filed Feb 12, 2021 02:49 UTC | BIOTELEMETRY, INC. BEAT · Entity 142764 | Disposition to issuerStock Options (Right to Buy) · Derivative | 29,040 | $61.64 Strike: $10.36 | $1,790,025.60 |
DisclosureSEC source: 0000899243-21-006176 · doc4.xml · derivative · entry 3 Getz Heather C · CIK 0001481485 · EVP, CFO & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 29,040 shares Expires 2025-02-16 F3 · derivative.exercise_date: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the total number of shares of Company common stock subject to such stock option immediately prior to the Effective Time, and (ii) the excess, if any, of the Offer Price over the exercise price per share of such stock option, less applicable withholding taxes. Read SEC document |
| February 09, 2021 Filed Feb 12, 2021 02:49 UTC | BIOTELEMETRY, INC. BEAT · Entity 142764 | Disposition to issuerStock Options (Right to Buy) · Derivative | 23,578 | $63.32 Strike: $8.68 | $1,492,958.96 |
DisclosureSEC source: 0000899243-21-006176 · doc4.xml · derivative · entry 2 Getz Heather C · CIK 0001481485 · EVP, CFO & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,578 shares Expires 2024-02-14 F3 · derivative.exercise_date: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the total number of shares of Company common stock subject to such stock option immediately prior to the Effective Time, and (ii) the excess, if any, of the Offer Price over the exercise price per share of such stock option, less applicable withholding taxes. Read SEC document |
| February 09, 2021 Filed Feb 12, 2021 02:49 UTC | BIOTELEMETRY, INC. BEAT · Entity 142764 | Disposition to issuerCommon Stock | 49,947 | $72.00 | $3,596,184.00 |
DisclosureSEC source: 0000899243-21-006176 · doc4.xml · nonDerivative · entry 1 Getz Heather C · CIK 0001481485 · EVP, CFO & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Per the terms of the Agreement and Plan of Merger, dated as of December 18, 2020, among the Company, Philips Holding USA Inc., a Delaware corporation, and Davies Merger Sub, Inc., a Delaware corporation (the "Merger Agreement") and the Offer (as defined in the Merger Agreement), each share of Company common stock was validly tendered for $72.00 per share in cash (the "Offer Price"), less any applicable withholding taxes. F2 · shares: Includes 21,390 restricted stock units that, pursuant to the Merger Agreement, were cancelled at the Effective Time of the Merger (both as defined in the Merger Agreement) and converted into the right to receive the Offer Price, less any applicable withholding taxes. Read SEC document |
| February 18, 2020 Filed Feb 21, 2020 01:57 UTC | BIOTELEMETRY, INC. BEAT · Entity 142764 | GrantStock Options (Right to Buy) · Derivative | 10,635 | $0.00 Strike: $53.22 | $0.00 |
DisclosureSEC source: 0001574774-20-000023 · wf-form4_158225022768233.xml · derivative · entry 2 Getz Heather C · CIK 0001481485 · EVP, CFO & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,635 Underlying: Common Stock · 10,635 shares Expires 2030-02-17 F2 · derivative.exercise_date: The options shall vest in equal amounts on each of the first four anniversaries of the grant date (February 17, 2020), provided that the Reporting Person remains in continuous service through the applicable vesting date. Read SEC document |
| February 18, 2020 Filed Feb 21, 2020 01:57 UTC | BIOTELEMETRY, INC. BEAT · Entity 142764 | GrantCommon Stock | 9,467 | $0.00 | $0.00 |
DisclosureSEC source: 0001574774-20-000023 · wf-form4_158225022768233.xml · nonDerivative · entry 1 Getz Heather C · CIK 0001481485 · EVP, CFO & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,183 F1 · shares: Represents shares of the Issuer's common stock underlying restricted stock units ("RSUs") awarded to the Reporting Person. The RSUs will vest in full on the third anniversary of the grant date (February 17, 2020), subject to accelerated vesting upon certain terminations of employment following certain corporate transactions involving the Issuer. The shares of common stock underlying the RSUs will be issued when the RSUs vest. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 01:27 UTC | BIOTELEMETRY, INC. BEAT · Entity 142764 | Tax withholdingCommon Stock | 2,757 | $53.52 | $147,554.64 |
DisclosureSEC source: 0001574774-20-000014 · wf-form4_158216202506604.xml · nonDerivative · entry 1 Getz Heather C · CIK 0001481485 · EVP, CFO & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,122 F1 · shares: Represents shares withheld to cover taxes in connection with the Reporting Person's February 14, 2017, RSU Grant. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 01:00 UTC | BIOTELEMETRY, INC. BEAT · Entity 142764 | Tax withholdingCommon Stock | 5,628 | $77.59 | $436,676.52 |
DisclosureSEC source: 0001574774-19-000010 · wf-form4_155062439241130.xml · nonDerivative · entry 2 Getz Heather C · CIK 0001481485 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,879 F2 · shares: Represents shares withheld to cover taxes in connection with the Reporting Person's February 15, 2016, RSU Grant. Read SEC document |
| February 14, 2019 Filed Feb 20, 2019 01:00 UTC | BIOTELEMETRY, INC. BEAT · Entity 142764 | GrantStock Options (Right to Buy) · Derivative | 9,395 | $0.00 Strike: $76.01 | $0.00 |
DisclosureSEC source: 0001574774-19-000010 · wf-form4_155062439241130.xml · derivative · entry 3 Getz Heather C · CIK 0001481485 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,395 Underlying: Common Stock · 9,395 shares Expires 2029-02-14 F3 · derivative.exercise_date: The options shall vest in equal amounts on each of the first four anniversaries of the grant date, provided that the option holder remains in continuous service through the applicable vesting date. Read SEC document |
| February 14, 2019 Filed Feb 20, 2019 01:00 UTC | BIOTELEMETRY, INC. BEAT · Entity 142764 | GrantCommon Stock | 3,946 | $0.00 | $0.00 |
DisclosureSEC source: 0001574774-19-000010 · wf-form4_155062439241130.xml · nonDerivative · entry 1 Getz Heather C · CIK 0001481485 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,507 F1 · shares: Represents shares of the Issuer's common stock underlying restricted stock units (RSUs) awarded to the Reporting Person. The RSUs will vest in full on the third anniversary of the grant date, subject to accelerated vesting upon certain terminations of employment following certain corporate transactions involving the Issuer. The shares of common stock underlying the RSUs will be issued when the RSUs vest. Read SEC document |
| February 01, 2019 Filed Feb 1, 2019 22:35 UTC | BIOTELEMETRY, INC. BEAT · Entity 142764 | Exercise / conversionStock Options (Right to Buy) · Derivative | 10,490 | $0.00 Strike: $2.80 | $0.00 |
DisclosureSEC source: 0001574774-19-000006 · wf-form4_154906049430857.xml · derivative · entry 6 Getz Heather C · CIK 0001481485 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,490 shares Expires 2022-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options vested in four equal annual installments, which began on December 31, 2012. The options were fully exercisable as of December 31, 2015. Read SEC document |
| February 01, 2019 Filed Feb 1, 2019 22:35 UTC | BIOTELEMETRY, INC. BEAT · Entity 142764 | SaleCommon Stock | 10,490 | $70.41 | $738,600.90 |
DisclosureSEC source: 0001574774-19-000006 · wf-form4_154906049430857.xml · nonDerivative · entry 4 Getz Heather C · CIK 0001481485 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,561 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $70.00 to $72.12, inclusive. The reporting person undertakes to provide to BioTelemetry, Inc., any security holder of BioTelemetry, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| February 01, 2019 Filed Feb 1, 2019 22:35 UTC | BIOTELEMETRY, INC. BEAT · Entity 142764 | Exercise / conversionCommon Stock | 10,490 | $2.80 | $29,372.00 |
DisclosureSEC source: 0001574774-19-000006 · wf-form4_154906049430857.xml · nonDerivative · entry 3 Getz Heather C · CIK 0001481485 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,051 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2019 Filed Feb 1, 2019 22:35 UTC | BIOTELEMETRY, INC. BEAT · Entity 142764 | Exercise / conversionStock Options (Right to Buy) · Derivative | 100 | $0.00 Strike: $2.80 | $0.00 |
DisclosureSEC source: 0001574774-19-000006 · wf-form4_154906049430857.xml · derivative · entry 5 Getz Heather C · CIK 0001481485 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,490 Underlying: Common Stock · 100 shares Expires 2022-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options vested in four equal annual installments, which began on December 31, 2012. The options were fully exercisable as of December 31, 2015. Read SEC document |
| January 31, 2019 Filed Feb 1, 2019 22:35 UTC | BIOTELEMETRY, INC. BEAT · Entity 142764 | SaleCommon Stock | 100 | $70.01 | $7,001.00 |
DisclosureSEC source: 0001574774-19-000006 · wf-form4_154906049430857.xml · nonDerivative · entry 2 Getz Heather C · CIK 0001481485 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,561 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2018. Read SEC document |
| January 31, 2019 Filed Feb 1, 2019 22:35 UTC | BIOTELEMETRY, INC. BEAT · Entity 142764 | Exercise / conversionCommon Stock | 100 | $2.80 | $280.00 |
DisclosureSEC source: 0001574774-19-000006 · wf-form4_154906049430857.xml · nonDerivative · entry 1 Getz Heather C · CIK 0001481485 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,661 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2019 Filed Jan 29, 2019 21:29 UTC | BIOTELEMETRY, INC. BEAT · Entity 142764 | Exercise / conversionStock Options (Right to Buy) · Derivative | 200 | $70.00 Strike: $2.80 | $14,000.00 |
DisclosureSEC source: 0001574774-19-000005 · wf-form4_154879733744732.xml · derivative · entry 11 Getz Heather C · CIK 0001481485 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,590 Underlying: Common Stock · 200 shares Expires 2022-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The stock options vested in four equal annual installments, which began on December 31, 2012. The options were fully exercisable as of December 31, 2015. Read SEC document |
| January 29, 2019 Filed Jan 29, 2019 21:29 UTC | BIOTELEMETRY, INC. BEAT · Entity 142764 | SaleCommon Stock | 200 | $70.00 | $14,000.00 |
DisclosureSEC source: 0001574774-19-000005 · wf-form4_154879733744732.xml · nonDerivative · entry 7 Getz Heather C · CIK 0001481485 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,561 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2018. Read SEC document |
| January 29, 2019 Filed Jan 29, 2019 21:29 UTC | BIOTELEMETRY, INC. BEAT · Entity 142764 | Exercise / conversionCommon Stock | 200 | $2.80 | $560.00 |
DisclosureSEC source: 0001574774-19-000005 · wf-form4_154879733744732.xml · nonDerivative · entry 6 Getz Heather C · CIK 0001481485 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,761 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.